Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation.

@article{Hirayama2005AngiotensinconvertingEI,
  title={Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation.},
  author={Yoshiyuki Hirayama and Hirotsugu Atarashi and Yoshinori Kobayashi and Tsutomu Horie and Yuuki Iwasaki and Mitsunori Maruyama and Yasushi Miyauchi and Toshihiko Ohara and Masaaki Yashima and Teruo Takano},
  journal={Circulation journal : official journal of the Japanese Circulation Society},
  year={2005},
  volume={69 6},
  pages={671-6}
}
BACKGROUND Atrial fibrillation is a progressive disease, which in the paroxysmal form (PAF) becomes more frequent and finally becomes chronic (CAF). A retrospective analysis of patients with PAF was conducted to examine the hypothesis that angiotensin-converting enzyme inhibitors (ACEI) will prevent the progression to CAF. METHODS AND RESULTS On the basis of their treatment, 95 patients with PAF were divided into 2 groups: 42 patients treated with ACEI for hypertension throughout the period… CONTINUE READING